BMCM
FBIO icon

Black Maple Capital Management’s Fortress Biotech FBIO Stock Holding History

Black Maple Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000
Closed -$4.36K – 100
2023
Q3 		$4.36K Hold
1,000
– – ﹤0.01% 107
2023
Q2 		$8.25K Hold
1,000
– – ﹤0.01% 99
2023
Q1 		$12.3K Hold
1,000
– – 0.01% 80
2022
Q4 		$9.82K Buy
+1,000
New +$11.1K 0.01% 54

Other funds holding FBIO

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Black Maple Capital Management's FBIO Position: Q4 2023 in Review

Black Maple Capital Management sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 1,000 shares — an estimated $4.36K sold.

Black Maple Capital Management first reported a position in FBIO in Q4 2022 and held it in 4 quarters. The position peaked at $12.3K in Q1 2023. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

  • Black Maple Capital Management reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
  • Black Maple Capital Management sold 1,000 Fortress Biotech shares in Q4 2023, an estimated $4.36K.
  • Black Maple Capital Management first reported a position in Fortress Biotech in Q4 2022 and held it in 4 quarters.
  • Black Maple Capital Management's Fortress Biotech position peaked at $12.3K in Q1 2023.
  • 42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on Black Maple Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.